Remission & chronicity
Biomarker Targets & Therapeutic Agents
Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: Clinical > Mechanistic > Correlative.
GABRA1
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| PICROTOXIN | ? unclear | Mechanistic | DGIdb | |
| THIAMYLAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| GANAXOLONE | ~ modulates | Mechanistic | DGIdb | |
| BUTOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| CHLORDIAZEPOXIDE | ~ modulates | Mechanistic | DGIdb | |
| CLOBAZAM | ~ modulates | Mechanistic | DGIdb | |
| CLORAZEPATE | ? unclear | Mechanistic | DGIdb | |
| TPA023 | ~ modulates | Mechanistic | DGIdb | |
| ZK-93423 | ? unclear | Mechanistic | DGIdb | |
| FLUMAZENIL | ~ modulates | Mechanistic | 3.3 nM (Ki) | DGIdb |
| AMOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| PAGOCLONE | ~ modulates | Mechanistic | DGIdb | |
| OXAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| TETRAHYDRODEOXYCORTICOSTERONE | ~ modulates | Mechanistic | DGIdb | |
| METHOHEXITAL | ? unclear | Mechanistic | DGIdb | |
| CLONAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| [3H]GABAZINE | ↓ inhibits | Mechanistic | DGIdb | |
| FLURAZEPAM | ? unclear | Mechanistic | DGIdb | |
| METHARBITAL | ~ modulates | Mechanistic | DGIdb | |
| LORAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| RO4938581 | ~ modulates | Mechanistic | DGIdb | |
| SECOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| BUTABARBITAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| MIDAZOLAM HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| SANDARACOPIMARIC ACID | ? unclear | Mechanistic | DGIdb | |
| QUAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| PHENOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| PRIMIDONE | ~ modulates | Mechanistic | DGIdb | |
| ISOGUVACINE | ↑ activates | Mechanistic | DGIdb | |
| ZOLPIDEM TARTRATE | ~ modulates | Mechanistic | DGIdb | |
| CHEMBL:CHEMBL2170369 | ? unclear | Mechanistic | DGIdb | |
| ESTAZOLAM | ~ modulates | Mechanistic | DGIdb | |
| TOPIRAMATE | ~ modulates | Mechanistic | DGIdb | |
| ETHCHLORVYNOL | ~ modulates | Mechanistic | DGIdb | |
| CLORAZEPATE DIPOTASSIUM | ~ modulates | Mechanistic | DGIdb | |
| ZALEPLON | ~ modulates | Mechanistic | DGIdb | |
| FLUNITRAZEPAM | ~ modulates | Mechanistic | 4.5 nM (Kd) | DGIdb |
| BUTABARBITAL | ? unclear | Mechanistic | DGIdb | |
| THIAMYLAL | ? unclear | Mechanistic | DGIdb | |
| BUTALBITAL | ~ modulates | Mechanistic | DGIdb |
Showing top 40 of 302 agents ranked by evidence tier.
GRIA1
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| PIRACETAM | ~ modulates | Mechanistic | DGIdb | |
| RECOMBINANT FIBROBLAST GROWTH FACTOR 2 | ? unclear | Mechanistic | DGIdb | |
| ANIRACETAM | ~ modulates | Mechanistic | DGIdb | |
| SODIUM CHLORIDE | ? unclear | Mechanistic | DGIdb | |
| NBQX | ↓ inhibits | Mechanistic | 1600.0 nM (Ki) | DGIdb |
| HALOPERIDOL DECANOATE | ? unclear | Mechanistic | DGIdb | |
| GYKI53655 | ↓ inhibits | Mechanistic | DGIdb | |
| SELURAMPANEL | ↓ inhibits | Mechanistic | DGIdb | |
| PHENOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| ARGIOTOXIN | ↓ inhibits | Mechanistic | DGIdb | |
| MK-8777 | ~ modulates | Mechanistic | DGIdb | |
| TALAMPANEL | ↓ inhibits | Mechanistic | DGIdb | |
| PERAMPANEL | ↓ inhibits | Mechanistic | 1180.0 nM (IC50) | DGIdb |
| FARAMPATOR | ~ modulates | Mechanistic | DGIdb | |
| ISOFLURANE | ? unclear | Mechanistic | DGIdb | |
| LY503430 | ~ modulates | Mechanistic | DGIdb | |
| TEZAMPANEL | ↓ inhibits | Mechanistic | DGIdb | |
| PESAMPATOR | ~ modulates | Mechanistic | DGIdb | |
| CX516 | ~ modulates | Mechanistic | DGIdb | |
| OSAVAMPATOR | ~ modulates | Mechanistic | DGIdb | |
| [3H]AMPA | ↑ activates | Mechanistic | DGIdb | |
| DESFLURANE | ? unclear | Mechanistic | DGIdb | |
| SEVOFLURANE | ? unclear | Mechanistic | DGIdb | |
| CX-717 | ? unclear | Mechanistic | DGIdb | |
| [3H]CNQX | ↓ inhibits | Mechanistic | DGIdb | |
| LY404187 | ~ modulates | Mechanistic | DGIdb | |
| ASPARAGINE | ? unclear | Mechanistic | DGIdb | |
| CYCLOTHIAZIDE | ~ modulates | Mechanistic | 1000.0 nM (EC50) | DGIdb |
| S18986 | ~ modulates | Mechanistic | DGIdb | |
| CX1739 | ~ modulates | Mechanistic | DGIdb | |
| IDRA-21 | ~ modulates | Mechanistic | DGIdb | |
| LY392098 | ~ modulates | Mechanistic | DGIdb | |
| FLUORO-WILLARDIINE | ↑ activates | Mechanistic | DGIdb | |
| GYKI53784 | ↓ inhibits | Mechanistic | DGIdb | |
| ZONAMPANEL | ↓ inhibits | Mechanistic | DGIdb | |
| ATPO | ↓ inhibits | Mechanistic | DGIdb | |
| ANESTHETIC AGENT | ? unclear | Mechanistic | DGIdb | |
| JORO SPIDER TOXIN | ↓ inhibits | Mechanistic | DGIdb | |
| CX546 | ~ modulates | Mechanistic | DGIdb | |
| DASOLAMPANEL | ↓ inhibits | Mechanistic | DGIdb |
Showing top 40 of 161 agents ranked by evidence tier.
GRIN1
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| AV-101 | ↓ inhibits | Mechanistic | DGIdb | |
| COMPOUND 8 [PMID: 17562362} | ↓ inhibits | Mechanistic | DGIdb | |
| KETAMINE HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| SERINE, D- | ↑ activates | Mechanistic | DGIdb | |
| 5,7-DICHLOROKYNURENIC ACID | ↓ inhibits | Mechanistic | DGIdb | |
| PHILANTHOTOXIN 343 | ? unclear | Mechanistic | DGIdb | |
| FELBAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| AMANTADINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| (+)-HA966 | ↑ activates | Mechanistic | DGIdb | |
| NEBOGLAMINE | ~ modulates | Mechanistic | DGIdb | |
| AZD8108 | ↓ inhibits | Mechanistic | DGIdb | |
| CNS-5161 | ? unclear | Mechanistic | DGIdb | |
| D-SERINE | ? unclear | Mechanistic | DGIdb | |
| GLYCINE | ↑ activates | Mechanistic | DGIdb | |
| [3H]CGP39653 | ↓ inhibits | Mechanistic | DGIdb | |
| EVT-101 | ↓ inhibits | Mechanistic | DGIdb | |
| DEXANABINOL | ? unclear | Mechanistic | DGIdb | |
| ORPHENADRINE | ? unclear | Mechanistic | DGIdb | |
| TRAXOPRODIL | ↓ inhibits | Mechanistic | DGIdb | |
| ESKETAMINE HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| ESKETAMINE | ~ modulates | Mechanistic | DGIdb | |
| MEMANTINE HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| DELUCEMINE | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]L689560 | ↓ inhibits | Mechanistic | DGIdb | |
| RALFINAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| APIMOSTINEL | ↑ activates | Mechanistic | DGIdb | |
| CYCLOSERINE | ? unclear | Mechanistic | DGIdb | |
| [3H]CGP61594 | ↓ inhibits | Mechanistic | DGIdb | |
| GW468816 | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]CPP | ↓ inhibits | Mechanistic | DGIdb | |
| LATREPIRDINE | ? unclear | Mechanistic | DGIdb | |
| NBQX | ? unclear | Mechanistic | DGIdb | |
| [3H]CGS19755 | ↓ inhibits | Mechanistic | DGIdb | |
| ORPHENADRINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]D-ASPARTIC ACID | ↑ activates | Mechanistic | DGIdb | |
| ORPHENADRINE CITRATE | ↓ inhibits | Mechanistic | DGIdb | |
| (RS)-(TETRAZOL-5-YL)GLYCINE | ↑ activates | Mechanistic | DGIdb | |
| DIZOCILPINE | ? unclear | Mechanistic | DGIdb | |
| RADIPRODIL | ↓ inhibits | Mechanistic | DGIdb | |
| PERZINFOTEL | ↓ inhibits | Mechanistic | DGIdb |
Showing top 40 of 188 agents ranked by evidence tier.
GRIN2B
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| APIMOSTINEL | ↑ activates | Mechanistic | DGIdb | |
| L701324 | ↓ inhibits | Mechanistic | DGIdb | |
| FELBAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| METHYLPHENIDATE | ? unclear | Mechanistic | DGIdb | |
| CLOZAPINE | ? unclear | Mechanistic | DGIdb | |
| NVP-AAM077 | ↓ inhibits | Mechanistic | DGIdb | |
| GLYCINE | ↑ activates | Mechanistic | DGIdb | |
| SELFOTEL | ↓ inhibits | Mechanistic | DGIdb | |
| AMANTADINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| QUETIAPINE FUMARATE | ? unclear | Mechanistic | DGIdb | |
| L689560 | ↓ inhibits | Mechanistic | DGIdb | |
| LATREPIRDINE | ? unclear | Mechanistic | DGIdb | |
| MG2+ | ↓ inhibits | Mechanistic | DGIdb | |
| TRAXOPRODIL | ↓ inhibits | Mechanistic | 74.0 nM (IC50) | DGIdb |
| VALPROIC ACID | ? unclear | Mechanistic | DGIdb | |
| [3H]DIZOCILPINE | ↓ inhibits | Mechanistic | DGIdb | |
| CNS-5161 | ? unclear | Mechanistic | DGIdb | |
| NEBOGLAMINE | ~ modulates | Mechanistic | DGIdb | |
| NP-10679 | ? unclear | Mechanistic | DGIdb | |
| 5,7-DICHLOROKYNURENIC ACID | ↓ inhibits | Mechanistic | DGIdb | |
| GV196771A | ↓ inhibits | Mechanistic | DGIdb | |
| DIZOCILPINE | ↓ inhibits | Mechanistic | DGIdb | |
| INDANTADOL | ↓ inhibits | Mechanistic | DGIdb | |
| ESKETAMINE HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| SEVOFLURANE | ? unclear | Mechanistic | DGIdb | |
| LANICEMINE | ↓ inhibits | Mechanistic | DGIdb | |
| ASPARTIC ACID | ↑ activates | Mechanistic | DGIdb | |
| UBP141 | ↓ inhibits | Mechanistic | DGIdb | |
| DELUCEMINE | ↓ inhibits | Mechanistic | DGIdb | |
| S-DESCHLOROKETAMINE | ↓ inhibits | Mechanistic | DGIdb | |
| RAPASTINEL | ↑ activates | Mechanistic | DGIdb | |
| [3H]L689560 | ↓ inhibits | Mechanistic | DGIdb | |
| EVT-101 | ? unclear | Mechanistic | DGIdb | |
| [3H]D-ASPARTIC ACID | ↑ activates | Mechanistic | DGIdb | |
| [3H]MDL105519 | ↓ inhibits | Mechanistic | DGIdb | |
| ELIPRODIL | ? unclear | Mechanistic | 13.0 nM (Ki) | DGIdb |
| D-CCPENE | ↓ inhibits | Mechanistic | DGIdb | |
| N1-DANSYL-SPERMINE | ↓ inhibits | Mechanistic | DGIdb | |
| ESKETAMINE | ~ modulates | Mechanistic | DGIdb | |
| KETAMINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb |
Showing top 40 of 236 agents ranked by evidence tier.
KCNQ2
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| EZOGABINE | ↑ activates | Mechanistic | 350.0 nM (EC50) | DGIdb |
| ICA-27243 | ↑ activates | Mechanistic | DGIdb | |
| FLUPIRTINE | ↑ activates | Mechanistic | DGIdb | |
| (S)-N-[1-(3-MORPHOLIN-4-YL-PHENYL)-ETHYL]-3-PHENYL-ACRYLAMIDE | ↑ activates | Mechanistic | DGIdb | |
| GUANIDINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ICA-069673 | ↑ activates | Mechanistic | DGIdb | |
| ML252 | ↓ inhibits | Mechanistic | DGIdb | |
| PYRITHIONE ZINC | ↑ activates | Mechanistic | DGIdb | |
| TETRAMETHYLAMMONIUM | ↓ inhibits | Mechanistic | DGIdb | |
| TEDISAMIL | ↓ inhibits | Mechanistic | DGIdb | |
| XE991 | ↓ inhibits | Mechanistic | DGIdb | |
| QO-58 | ↑ activates | Mechanistic | DGIdb | |
| ICA-105665 | ? unclear | Mechanistic | DGIdb | |
| NERISPIRDINE | ↓ inhibits | Mechanistic | DGIdb | |
| CELECOXIB | ? unclear | Mechanistic | DGIdb | |
| AZETUKALNER | ↑ activates | Mechanistic | 98.0 nM (EC50) | DGIdb |
| AMIFAMPRIDINE PHOSPHATE | ↓ inhibits | Mechanistic | DGIdb | |
| PIP2 | ↑ activates | Mechanistic | DGIdb | |
| DALFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| LINOPIRDINE | ↓ inhibits | Mechanistic | DGIdb | |
| FLINDOKALNER | ↑ activates | Mechanistic | 2400.0 nM (EC50) | DGIdb |
| L735821 | ↓ inhibits | Mechanistic | DGIdb | |
| AMIFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| CHEMBL317935 | ↑ activates | Mechanistic | 3000.0 nM (EC50) | ChEMBL |
| CHEMBL100379 | ↑ activates | Mechanistic | 1200.0 nM (EC50) | ChEMBL |
| CHEMBL2164048 | ↓ inhibits | Mechanistic | 70.0 nM (IC50) | ChEMBL |
| CHEMBL2163678 | ↑ activates | Mechanistic | 27420.0 nM (EC50) | ChEMBL |
| CHEMBL2163670 | ↑ activates | Mechanistic | 7090.0 nM (EC50) | ChEMBL |
| CHEMBL2163668 | ↑ activates | Mechanistic | 8660.0 nM (EC50) | ChEMBL |
| CHEMBL2163666 | ↑ activates | Mechanistic | 1020.0 nM (EC50) | ChEMBL |
| CHEMBL2163686 | ↓ inhibits | Mechanistic | 14990.0 nM (IC50) | ChEMBL |
| CHEMBL2163350 | ↓ inhibits | Mechanistic | 5270.0 nM (IC50) | ChEMBL |
| CHEMBL2163673 | ↓ inhibits | Mechanistic | 12670.0 nM (IC50) | ChEMBL |
| CHEMBL2163667 | ↓ inhibits | Mechanistic | 210.0 nM (IC50) | ChEMBL |
| CHEMBL2163681 | ↑ activates | Mechanistic | 12270.0 nM (EC50) | ChEMBL |
| CHEMBL2163663 | ↑ activates | Mechanistic | 800.0 nM (EC50) | ChEMBL |
| CHEMBL1729184 | ↑ activates | Mechanistic | 1750.0 nM (EC50) | ChEMBL |
| CHEMBL2163660 | ↑ activates | Mechanistic | 170.0 nM (EC50) | ChEMBL |
| CHEMBL1320944 | ↑ activates | Mechanistic | 2350.0 nM (EC50) | ChEMBL |
| CHEMBL1572950 | ↑ activates | Mechanistic | 350.0 nM (EC50) | ChEMBL |
Showing top 40 of 117 agents ranked by evidence tier.
KCNQ3
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| LINOPIRDINE | ? unclear | Mechanistic | DGIdb | |
| AZETUKALNER | ↑ activates | Mechanistic | DGIdb | |
| JNJ-37822681 | ↑ activates | Mechanistic | DGIdb | |
| AMIFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| TEDISAMIL | ↓ inhibits | Mechanistic | DGIdb | |
| NERISPIRDINE | ↓ inhibits | Mechanistic | DGIdb | |
| TETRAMETHYLAMMONIUM | ↓ inhibits | Mechanistic | DGIdb | |
| GUANIDINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ICA-105665 | ? unclear | Mechanistic | DGIdb | |
| AMIFAMPRIDINE PHOSPHATE | ↓ inhibits | Mechanistic | DGIdb | |
| GABAPENTIN | ↑ activates | Mechanistic | DGIdb | |
| DALFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| FLINDOKALNER | ↑ activates | Mechanistic | 2400.0 nM (EC50) | DGIdb |
| EZOGABINE | ↑ activates | Mechanistic | 3900.0 nM (EC50) | DGIdb |
| CELECOXIB | ? unclear | Mechanistic | DGIdb | |
| CHEMBL4545892 | ↑ activates | Mechanistic | 10500.0 nM (EC50) | ChEMBL |
| CHEMBL4457044 | ↑ activates | Mechanistic | 920.0 nM (EC50) | ChEMBL |
KCNQ4
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| AMIFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| GUANIDINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| XE991 | ↓ inhibits | Mechanistic | DGIdb | |
| (S)-N-[1-(3-MORPHOLIN-4-YL-PHENYL)-ETHYL]-3-PHENYL-ACRYLAMIDE | ↑ activates | Mechanistic | DGIdb | |
| FLINDOKALNER | ↑ activates | Mechanistic | 2400.0 nM (EC50) | DGIdb |
| ML252 | ↓ inhibits | Mechanistic | DGIdb | |
| AMIFAMPRIDINE PHOSPHATE | ↓ inhibits | Mechanistic | DGIdb | |
| NC00075159 | ↑ activates | Mechanistic | DGIdb | |
| RETIGABINE DERIVATIVE 10G | ↑ activates | Mechanistic | DGIdb | |
| PIP2 | ↑ activates | Mechanistic | DGIdb | |
| TETRAMETHYLAMMONIUM | ↓ inhibits | Mechanistic | DGIdb | |
| TEDISAMIL | ↓ inhibits | Mechanistic | DGIdb | |
| CELECOXIB | ? unclear | Mechanistic | DGIdb | |
| ML213 | ↑ activates | Mechanistic | DGIdb | |
| ICA-105665 | ? unclear | Mechanistic | DGIdb | |
| BEPRIDIL | ↓ inhibits | Mechanistic | DGIdb | |
| PYRITHIONE ZINC | ↑ activates | Mechanistic | DGIdb | |
| DALFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| NERISPIRDINE | ↓ inhibits | Mechanistic | DGIdb | |
| LINOPIRDINE | ↓ inhibits | Mechanistic | DGIdb | |
| EZOGABINE | ↑ activates | Mechanistic | 5900.0 nM (EC50) | DGIdb |
| CHEMBL2164048 | ↓ inhibits | Mechanistic | 200.0 nM (IC50) | ChEMBL |
| CHEMBL3621437 | ↑ activates | Mechanistic | 625.0 nM (EC50) | ChEMBL |
| CHEMBL4287894 | ↑ activates | Mechanistic | 100.0 nM (EC50) | ChEMBL |
| CHEMBL4288707 | ↑ activates | Mechanistic | 160.0 nM (EC50) | ChEMBL |
| CHEMBL4287478 | ↑ activates | Mechanistic | 4000.0 nM (EC50) | ChEMBL |
| CHEMBL4277250 | ↑ activates | Mechanistic | 20.0 nM (EC50) | ChEMBL |
| CHEMBL1703636 | ↑ activates | Mechanistic | 1600.0 nM (EC50) | ChEMBL |
| CHEMBL4448132 | ↑ activates | Mechanistic | 890.0 nM (EC50) | ChEMBL |
| CHEMBL4450214 | ↑ activates | Mechanistic | 2030.0 nM (EC50) | ChEMBL |
| CHEMBL4588394 | ↑ activates | Mechanistic | 780.0 nM (EC50) | ChEMBL |
| CHEMBL4438770 | ↑ activates | Mechanistic | 1420.0 nM (EC50) | ChEMBL |
| CHEMBL4545892 | ↑ activates | Mechanistic | 100.0 nM (EC50) | ChEMBL |
| CHEMBL4457044 | ↑ activates | Mechanistic | 80.0 nM (EC50) | ChEMBL |
| CHEMBL5200636 | ↑ activates | Mechanistic | 320.0 nM (EC50) | ChEMBL |
| CHEMBL4458793 | ↑ activates | Mechanistic | 910.0 nM (EC50) | ChEMBL |
| CHEMBL5185685 | ↑ activates | Mechanistic | 87.0 nM (EC50) | ChEMBL |
| CHEMBL4549229 | ↑ activates | Mechanistic | 660.0 nM (EC50) | ChEMBL |
| CHEMBL5178988 | ↑ activates | Mechanistic | 6400.0 nM (EC50) | ChEMBL |
SLC6A4
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| CLOMIPRAMINE | ↓ inhibits | Mechanistic | 70.0 nM (IC50) | DGIdb |
| CITALOPRAM | ↓ inhibits | Mechanistic | 1.6 nM (Ki) | DGIdb |
| FLUVOXAMINE | ↓ inhibits | Mechanistic | DGIdb | |
| MILNACIPRAN | ↓ inhibits | Mechanistic | DGIdb | |
| PHENELZINE | ↓ inhibits | Mechanistic | DGIdb | |
| FLUOXETINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| 3,4-METHYLENEDIOXYMETHAMPHETAMINE | ? unclear | Mechanistic | DGIdb | |
| BL-1021 | ? unclear | Mechanistic | DGIdb | |
| FLUVOXAMINE MALEATE | ? unclear | Mechanistic | DGIdb | |
| VENLAFAXINE | ↓ inhibits | Mechanistic | 8.9 nM (Kd) | DGIdb |
| DESVENLAFAXINE FUMARATE | ↓ inhibits | Mechanistic | DGIdb | |
| DESVENLAFAXINE SUCCINATE | ↓ inhibits | Mechanistic | DGIdb | |
| NORTRIPTYLINE | ↓ inhibits | Mechanistic | DGIdb | |
| ACETAMINOPHEN | ? unclear | Mechanistic | DGIdb | |
| FAXELADOL | ↓ inhibits | Mechanistic | DGIdb | |
| TEDATIOXETINE | ? unclear | Mechanistic | DGIdb | |
| MINAPRINE | ? unclear | Mechanistic | DGIdb | |
| TRAZODONE | ? unclear | Mechanistic | DGIdb | |
| SERTRALINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| LIAFENSINE | ↓ inhibits | Mechanistic | DGIdb | |
| DAPOXETINE | ↓ inhibits | Mechanistic | DGIdb | |
| MAZINDOL | ↓ inhibits | Mechanistic | 50.0 nM (Ki) | DGIdb |
| VORTIOXETINE HYDROBROMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| COCAINE | ? unclear | Mechanistic | 270.0 nM (IC50) | DGIdb |
| DULOXETINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| PAROXETINE HYDROCHLORIDE, HEMIHYDRATE | ↓ inhibits | Mechanistic | DGIdb | |
| NORTRIPTYLINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| TRIMIPRAMINE | ↓ inhibits | Mechanistic | DGIdb | |
| LUMATEPERONE | ↓ inhibits | Mechanistic | DGIdb | |
| AMITIFADINE | ↓ inhibits | Mechanistic | DGIdb | |
| NEFAZODONE | ↓ inhibits | Mechanistic | 200.0 nM (Kd) | DGIdb |
| ATOMOXETINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| CHLORPHENTERMINE HYDROCHLORIDE | ? unclear | Mechanistic | DGIdb | |
| TRAZODONE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| DEXFENFLURAMINE | ? unclear | Mechanistic | DGIdb | |
| DOXEPIN HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| N-DESMETHYLCLOZAPINE | ? unclear | Mechanistic | DGIdb | |
| IBOGAINE | ↓ inhibits | Mechanistic | DGIdb | |
| LEVOMILNACIPRAN | ↓ inhibits | Mechanistic | DGIdb | |
| PSEUDOEPHEDRINE POLISTIREX | ? unclear | Mechanistic | DGIdb |
Showing top 40 of 234 agents ranked by evidence tier.
Clinical Trials
Drug, biologic and supplement trials (treatment or prevention) from ClinicalTrials.gov whose main condition is Tinnitus: recruiting, active or completed, most recently updated first. Data retrieved 2026-10-28.
Tinnitus is a persistent non-physiologic, non-psychiatric, ringing in the ear that affects up to 20% of the general US population. The purpose of this study is to assess the patient reported effectiveness of Xeomin (incobotulinumtoxinA) injections into the auricular muscles for relief of tinnitus wi...
The purpose of this multi-site research study is to determine if Etanercept, compared to a placebo, significantly reduces the severity of tinnitus (ringing in the ears) associated with history of blast and/or noise exposure or associated with Traumatic Brain Injury (TBI) and/or concussion. Individua...
This study tested whether a single dose of nicotine gum can reduce the loudness of tinnitus (ringing in the ears) in non-smoking adults with chronic tinnitus. Nicotine acts on brain nicotinic acetylcholine receptors that regulate the balance of excitation and inhibition in auditory and attention net...
This research aims to evaluate the effects of the drug olanzapine on the discomfort caused by tinnitus according to each patient's personality traits. Olanzapine is a drug used as an antipsychotic whose mechanism of action makes it potentially useful for the treatment of tinnitus.
Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. In addition, it contributes significant costs to the healthcare system. However, the mechanisms of tinnitus are poorly unde...
The primary objective of this study is to evaluate the safety and tolerability of brexanolone in participants with tinnitus following a single 6-hour continuous intravenous (IV) infusion.
This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily f...
The goal of this clinical trial is to investigate the efficacy of oral steroids in the acute tinnitus population. Participants will receive appropriate dosages of short-term prednisone and/or oral Ginkgo Biloba tablets.
The purpose of this study is to determine the efficacy of OTO-313 in subjects with unilateral tinnitus and to determine the safety and tolerability of OTO-313 in subjects with unilateral tinnitus.
The purpose of this study is to evaluate the safety, tolerability, plasma pharmacokinetics (PK), and exploratory efficacy of OTO-313 administered as an intratympanic injection for the treatment of subjective tinnitus.
To evaluate the effect of psychological/mental factors on the severity of subjective tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus complications, such as depression...
The purpose of this study is to assess the effectiveness of antioxidant supplementation in idiopathic tinnitus patients. To investigate this, a double-blind, randomized, and placebo-controlled clinical trial was conducted to assess the impact of a multivitamin-multimineral supplement with phytochemi...
Tinnitus is perception of sound without the presence of an external acoustic stimulus. Approximately 50 million Americans experience chronic tinnitus and of these, 10 million have bothersome tinnitus. The tinnitus research literature suggests that NMDA receptor antagonists may prove to be useful in ...
Agents Found By Disease-Level Search
Searched directly from “Tinnitus” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 8-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).
15 agents shown (approved or with trial evidence) — 12 not found by the gene-target search above.
Nortriptyline
Topiramate
Paroxetine
VerapamilNOT in gene-target list
SPI-1005 Ebselen 200mg Capsule x1NOT in gene-target list
SPI-1005 Ebselen 200mg Capsule x2NOT in gene-target list
SPI-1005 Ebselen 200mg Capsule x3NOT in gene-target list
Transdermal LidocaineNOT in gene-target list
Tele-PTMNOT in gene-target list
Wait List ControlNOT in gene-target list
SulodexideNOT in gene-target list
AcetazolamideNOT in gene-target list
MethylprednisolonNOT in gene-target list
AUT00063NOT in gene-target list
Levitra (Vardenafil, BAY38-9456)NOT in gene-target list
Generated by the Open Source Medicine Foundation Biomarker Pipeline — 2026-10-08. Data sources: DGIdb, Open Targets, ChEMBL, PubMed, ClinicalTrials.gov. Not medical advice.